Eli Lilly And Cao (NYSE:LLY) announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz).

The Texas Stock Exchange announced Friday it has filed Form 1 with the U.S. Securities and Exchange Commission, the first step on its journey towards approval as a national stock exchange.

TAMPERE, Finland, Jan. 31, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in absorbable orthopedic implants, has successfully completed its CE mark approval process and can start commercialization ...

According to a national study conducted by Emerson College Polling, President Trump has started his term with a 49% approval rating. He also got a 41% disapproval rate, while 10% are neutral.

Coinbase looks a little bit to the upside in pre-market trading, but again, it’s simply bouncing from a significant pullback into a large cluster of trading. So, while Coinbase looks like it ...

The stock was up 6.9% at $19.47 in premarket trading. Shares were trading at around $2.87 this time a year ago. The Midland, Texas company, which is developing a space-based cellular network ...

Ami Fadia has given his Buy rating due to a combination of factors including the recent approval of Axsome Therapeutics’ drug, Symbravo, for the acute treatment of migraine in adults.

The FDA’s approval of AXS-07, now commercialized as Symbravo, for treating acute migraine in adults is a significant positive step for the company. This approval not only diversifies Axsome’s ...

Vertex Pharmaceuticals won U.S. approval for the first new non-opioid painkiller in decades, which could be a blockbuster if the company can persuade insurers and doctors to embrace the non ...

An update from Merit Medical Systems ( (MMSI)) is now available. On January 28, 2025, Merit Medical Systems held a conference call to discuss their WRAPSODY™ Cell-Impermeable Endoprosthesis ...